叢狀蛋白B1(PLXNB1)多克隆抗體
Polyclonal Antibody to Plexin B1 (PLXNB1)
PLXN5; SEP; Semaphorin receptor SEP
- 編號PAH358Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPH358Mu01-叢狀蛋白B1(PLXNB1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.93mg/ml
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 648 ¥ 1512 ¥ 2160 ¥ 5400 ¥ 21600
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Samples: Mouse Liver Tissue; Primary Ab: 10μg/ml Rabbit Anti-Mouse PLXNB1 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Mouse Kidney Tissue;
Primary Ab: 10μg/ml Rabbit Anti-Mouse PLXNB1 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant PLXNB1, Mouse.
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對PLXNB1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別PLXNB1。
用法
Western blotting: 0.5-2μg/mL;1:460-1860
Immunohistochemistry: 5-20μg/mL;1:46-186
Immunocytochemistry: 5-20μg/mL;1:46-186
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPH358Mu01 | 叢狀蛋白B1(PLXNB1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAH358Mu01 | 叢狀蛋白B1(PLXNB1)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻
| 雜志 | 參考文獻 |
| Expert Opin Ther Targets. | Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment [Pubmed:25395071] |
| Clinical Lymphoma, Myeloma & Leukemia | A Revised Staging System for Waldenstr?m's Macroglobulinemia [10.1016/j.clml.2017.07.146] |
| Clinical Lymphoma, Myeloma & Leukemia | Extramedullary Multiple Myeloma: Clinical Features and Prognosis in Argentina [10.1016/j.clml.2017.07.144] |
| Blood?Cancer?Journal | Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma [Pubmed:29748532] |
留言咨詢
